Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06300294
Other study ID # AIBU-SBF-AYN-3
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date January 31, 2025

Study information

Verified date March 2024
Source Abant Izzet Baysal University
Contact hospital Chief physician, Dr
Phone 0 236 229 26 00
Email manisasehir@saglik.gov.tr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to examine the effect of acupressure on physiological parameters and anxiety levels in individuals diagnosed with Acute Coronary Syndrome (ACS). H1-1: Acupressure applied to individuals diagnosed with ACS has an effect on the level of anxiety. H1-2: Acupressure applied to individuals diagnosed with ACS has an effect on blood pressure. H1-3: Acupressure applied to individuals diagnosed with ACS has an effect on heart rate. H1-4: Acupressure applied to individuals diagnosed with ACS has an effect on respiratory rate. H1-5: Acupressure applied to individuals diagnosed with ACS has an effect on the pain level. H1-6: Acupressure applied to individuals diagnosed with ACS has an effect on cortisol levels.


Description:

Acute Coronary Syndrome (ACS) affects millions of people every year; It refers to three types of coronary artery disease: unstable angina pectoris, non-ST-elevation myocardial infarction (NSTE MI) and ST-elevation myocardial infarction (STEMI). It is known that 19 million people in the world and 161 thousand people in our country lost their lives due to Cardiovascular Disease (CVD). Approximately 3 million people worldwide die due to STEMI.Individuals experiencing ACS generally; It is observed that he/she experiences burning, stinging and compressive chest pain, tachycardia, sweating, fatigue, dizziness, dyspnea, nausea, anxiety and depression.Management of the disease is combined with pharmacological applications; It is tried to be provided with non-pharmacological applications such as education, acupuncture and acupressure. When the literature is examined, acupressure application; in the physiological parameters of individuals with myocardial infarction; It brings blood pressure, heart rate and respiratory rate to normal limits, and increases oxygen saturation and sleep quality; It appears to reduce anxiety and pain.For all these reasons, this study aims to examine the effect of acupressure on physiological parameters (blood pressure, heart rate, respiratory rate, pain and cortisol) and anxiety levels in individuals diagnosed with ACS.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 38
Est. completion date January 31, 2025
Est. primary completion date April 15, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Volunteer to participate in the study, - Those aged 18 and over - Able to speak Turkish - Diagnosed with ACS for the first time - Cardiopulmonary resuscitation not applied - No orientation problems (those who score 15 on the Glasgow Coma Scale) - Not diagnosed with psychiatric disease - No amputation, fistula, lymphedema, neuropathy or hemiplegia in any of the Upper Extremities - Those who underwent femoral intervention for CAG procedure - Those who have not used any integrative practices based on pressure and stimulation such as acupressure, acupuncture and reflexology in the last month. - Vital signs (28) are within normal range: Blood pressure: 90/60-120/80 mmHg Heart rate: 60-100 min Respiratory rate: 12-18 min Exclusion Criteria: - Those with arrhythmia (AF, VT etc.) - Patients who have previously undergone Coronary Angiography - Diagnosed with myocarditis, pericarditis - Those who do not take any speed-breaking drugs (beloc, arlec, etc.). - Patients who underwent radial intervention for CAG procedure

Study Design


Related Conditions & MeSH terms


Intervention

Other:
acupressure
After the CAG procedure, acupressure will be applied to individuals whose vital signs are within the normal range.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Abant Izzet Baysal University

Outcome

Type Measure Description Time frame Safety issue
Primary means of blood pressure In this study, blood pressure was measured using monitors in the intensive care unit. up to 30 minutes
Primary means of hear rate Heart rate is the pressure exerted on the vessel wall by the blood thrown by the left ventricle from the skin surface to the aorta during systole. In the research, heart rate is measured using a monitor. up to 30 minutes
Primary means of respiratory rate Respiratory rate is the patient's breaths per minute. In this study, respiratory rate was taken from the monitor. up to 30 minutes
Primary means of cortisol. The cortisol value in the blood will be measured. up to 60 minutes
Secondary means of subjective anxiety scores. numerical anxiety scale. The total score between 0-10 obtained. up to 30 minutes
Secondary means of subjective pain scores. visual analog scale. It consists of a straight line with endpoints that define end limits such as "no pain" and "pain as bad as possible". The patient is asked to mark the level of pain on the line between the two endpoints. up to 30 minutes
Secondary electrocardiography evaluation Electrocardiography is the process of recording the electrical activity occurring in the heart to examine the functioning of the heart muscle and neural conduction system. up to 30 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study